Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001818382-25-000020
Filing Date
2025-01-23
Accepted
2025-01-23 16:34:58
Documents
1
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1737668091.html 4  
1 FORM 4 wk-form4_1737668091.xml 4 3989
  Complete submission text file 0001818382-25-000020.txt   5549
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 620 WADE AVENUE UNIT 501 RALEIGH NC 27605
Business Address
Scheessele William John (Reporting) CIK: 0001879378 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39532 | Film No.: 25550596